Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia

被引:59
作者
González-Barca, E
Fernández-Sevilla, A
Carratalá, J
Salar, A
Peris, J
Grañena, A
Gudiol, F
机构
[1] Hosp Duran & Reynals, Ciutat Sanitara & Univ Bellvitge, Dept Hematol, Inst Catala Oncol, E-08907 Barcelona, Spain
[2] Ciutat Sanitaria & Univ Bellvitge, Dept Infect Dis, E-08907 Barcelona, Spain
关键词
D O I
10.1007/s100960050345
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The purpose of this study was to identify risk factors for mortality in neutropenic patients with cancer and bacteremia. A consecutive sample of 438 neutropenic patients (granulocyte count <0.5 x 10(9)/1) with cancer and bacteremia was studied to identify the clinical characteristics associated with mortality at the onset of bacteremia. The mean age of the subjects was 48 years (range, 15-87 years). Most cases of bacteremia (77%) were hospital-acquired and occurred in patients with acute leukemia (48%). Gram-positive organisms caused 233 (53%) episodes of bacteremia, gram-negative organisms caused 151 (34%) episodes, and 48 (11%) episodes were polymicrobial. The overall mortality within 30 days of the onset of bacteremia was 24.4%. The variables found to be independently associated with increased mortality using logistic regression techniques were as follows: shock at the onset of bacteremia (OR, 10; 95% CI, 4.2-23.8), pneumonia (OR,4.4; 95% CI, 1.9-10), uncontrolled cancer (OR,4.3; 95% CI, 1.5-12.7), and absence of prophylaxis with norfloxacin (OR,2.4; 95% CI, 1.3-1.5). The prognostic factors ascertained in this study may help to identify those patients at higher risk of death. Medical intervention addressing some of these factors may improve the outcome of bacteremia in neutropenic patients with cancer.
引用
收藏
页码:539 / 544
页数:6
相关论文
共 27 条
[1]  
[Anonymous], 1978, J INFECT DIS
[2]   PEFLOXACIN AND VANCOMYCIN VS GENTAMICIN, COLISTIN SULFATE AND VANCOMYCIN FOR PREVENTION OF INFECTIONS IN GRANULOCYTOPENIC PATIENTS - A RANDOMIZED DOUBLE-BLIND-STUDY [J].
ARCHIMBAUD, E ;
GUYOTAT, D ;
MAUPAS, J ;
PLOTON, C ;
NAGEOTTE, A ;
DEVAUX, Y ;
THOMAS, X ;
FLEURETTE, J ;
FIERE, D .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (02) :174-178
[3]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[4]   COMPARISON OF NORFLOXACIN WITH COTRIMOXAZOLE FOR INFECTION PROPHYLAXIS IN ACUTE-LEUKEMIA - THE TRADE-OFF FOR REDUCED GRAM-NEGATIVE SEPSIS [J].
BOW, EJ ;
RAYNER, E ;
LOUIE, TJ .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (05) :847-854
[5]  
Breslow NE, 1980, SCI PUBLICATION INT
[6]   EMERGENCE OF QUINOLONE-RESISTANT ESCHERICHIA-COLI BACTEREMIA IN NEUTROPENIC PATIENTS WITH CANCER WHO HAVE RECEIVED PROPHYLACTIC NORFLOXACIN [J].
CARRATALA, J ;
FERNANDEZSEVILLA, A ;
TUBAU, F ;
CALLIS, M ;
GUDIOL, F .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :557-560
[7]   Bacteremic pneumonia in neutropenic patients with cancer -: Causes, empirical antibiotic therapy, and outcome [J].
Carratalà, J ;
Rosón, B ;
Fernández-Sevilla, A ;
Alcaide, F ;
Gudiol, F .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (08) :868-872
[8]   Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis [J].
Carratala, J ;
FernandezSevilla, A ;
Dominguez, FTMA ;
Gudiol, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :503-505
[9]  
*CDC, 1972, NAT NOS INF STUD SIT, P82
[10]   ESCHERICHIA-COLI RESISTANT TO FLUOROQUINOLONES IN PATIENTS WITH CANCER AND NEUTROPENIA [J].
COMETTA, A ;
CALANDRA, T ;
BILLE, J ;
GLAUSER, MP .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) :1240-1241